Human immunodefi ciency virus type 1-infected patients with syphilis are among the most important transmitters of HIV-1 infection due to biological effects of genital ulcerations, and aggravation due to their continued risky behavior. The association between primary syphilis and acute HIV-1 co-infection is not well documented, and reports on isolated cases are raising special interest and indicate that this double primary co-infection may occur. We present a case of a 31-year-old man with no past medical history who presented with fever, papular rash on the face which lasted for a few days, and a single genital ulcer. He was diagnosed with primary syphilis and primary HIV-1 infection after a single exposure with an infected female sex worker. Male-to-female HIV transmission during vaginal intercourse is signifi cantly more likely than female-to-male HIV transmission. However, high prevalence of sexually transmitted diseases among female sex workers contributed to high HIV transmission probability, as in our case. As far as the available world literature is concerned, this is the fi rst case of co-infection of primary syphilis and HIV.
Currently, syphilis and HIV go hand in hand, since they aff ect similar subgroups, facilitate the acquisition of each other, and may aggravate the clinical course of both diseases. Th e main way of transmission is among high risk groups, such as men who have sex with men, sex workers and drug users (4) .
Case report
A 31-year-old man of Asian origin was admitted with a week history of small painful ulcers of the soft palate, tongue erythema and a single well defi ned fi rm, painless ulcer on the penis with adjacent inguinal lymphadenopathy. He also had multiple erythematous facial papules. On admission he was febrile, dehydrated, with a cachectic appearance. He received oral antibiotics and antivirals in the last 24 hours with no improvement. S yphilis is one of the most prevalent infections in people living with HIV/AIDS (human immunodefi ciency virus/acquired immune defi ciency syndrome). According to a recent research which estimated the prevalence of sexually transmitted infections (STI) in this group, the reported rates of syphilis co-infection in HIV-infected individuals range from 1%-21% in North America to 2%-43% in Europe (1) . An increased prevalence of syphilis all over the world has been reported in the past 10 years, particularly after the introduction of highly active antiretroviral therapy (HAART) for AIDS in 1996, which was followed by increase in unsafe anal sex in men who have sex with men (MSM) (2) . In addition, sporadic unconnected outbreaks of heterosexually transmitted syphilis associated with commercial sex workers, migration, and partner swapping have been documented (3) .
Th e patient had no signifi cant medical history; he reported no history of recent travel, medication or illicit drug use. He had a single unprotected sexual intercourse (oral and vaginal sex) with a female illegal sex worker about 4 weeks before the onset of lesions. He claimed he did not have sex in the past three years.
Laboratory tests showed negative direct microscopy fi ndings from the penile lesion for Treponema pallidum, a weakly positive VDRL test (Venereal Disease Research Laboratory), positive T. Pallidum enzyme immunoassay (EIA) for IgM and IgG and positive test results for Treponema pallidum particle agglutination (TP-PA) (Fujirebio, Belgium) with a titer 1 : 2560, indicating syphilis infection. Routine ELISA HIV antibody test (Vironostika, France) was positive, but Western-blot (Fujirebio, Belgium) which is the gold standard for the detection of antibodies to HIV-1 was negative, while lymphocytopenia with a CD4/CD8 ratio of 0.124 raised suspicion of an overlap between primary HIV and syphilis infection. Th e patient was successfully treated for syphilis with 2,4 millions of intramuscular benzathine penicillin G. On a follow up visit after a month of treatment, VDRL test was negative, Western-blot turned out to be strongly positive; CD4 T lymphocyte count was 406 cells/mm 3 of blood (normally 500 -1,200), with a high total viral load of 140.000/ml of blood. Clinically, the genital ulcer resolved after a week of treatment, leaving an area of hyperpigmentation, and facial papules also disappeared within 3 weeks. Th e patient was diagnosed with primary co-infection of syphilis and HIV.
Discussion
A striking increase in the prevalence of concomitant human immunodefi ciency virus (HIV) infection and syphilis, observed by clinicians and public health workers over the past decade, has renewed interest in the subject. Th e aforementioned diff erences in the prevalence of syphilis in HIV-infected individuals within diff erent studies may be due to sampling, study design, diagnostic tests, or potentially temporal factors (5) . Concomitant syphilis and HIV infection are particularly common among men who have Figure 1 . Penile lesion on admission sex with men (MSM) and sex workers (6) . Several studies have reported the rate of HIV and syphilis co-infection as high as 50% (7, 8) . Moreover, in a crosssectional study conducted among HIV infected patients who attended the AIDS Outpatient Clinic in Victoria (Brazil), the prevalence of syphilis infection turned to be high as well, while syphilis infection was independently associated with male gender, history of male to male sex, current use of antiretroviral therapy, and history of syphilis infection (5) . Nevertheless, to the best of our knowledge, there has been no report published in the world literature on primary co-infection of both syphilis and HIV after a single exposure.
Both syphilis and HIV typically present with primary lesions/symptoms between 2 to 6 weeks after exposure to Treponema pallidum and HIV-1, respectively. Although syphilis presentation in patients with HIV is largely similar to that in patients without HIV, diff erences in disease manifestation may be present (9, 10) . Syphilis usually takes a more malignant course, although asymptomatic primary syphilis can also been seen (4). Serologic tests for syphilis in HIV-infected persons may be modifi ed as well, showing extremely high titer s, as in our patient.
Acute HIV (AHI) infection, with a duration of a few weeks to two months, is the earliest stage of HIV disease, when plasma HIV viremia can be detected, but before HIV antibodies can be measured (11) (12) (13) . Forty to ninety percents of newly-infected persons may present with a clinical picture that represents a diagnostic challenge, usually described as "the worst fl u ever" or "acute retroviral syndrome" (ARS) (13) . Nonspecifi c symptoms called ARS or"primary HIV infection", are the body's natural response to the HIV infection and include fever, fatigue, pharyngitis, weight loss, night sweats, lymphadenopathy, myalgias, joint pain, headache, nausea and diarrhea. Rash or mucocutaneous ulcers can also be present (11) . More specifi c symptoms, such as photophobia, and retroorbital pain may develop as well. Development of the classic mononucleosis-like symptoms coincides with high level viremia, as in our patient, and may last several days up to several weeks. Initial viremia has been reported to be as early as 4-11 days, while clinically detectable viremia may be more delayed (12) . Leukopenia and/or thrombocytopenia, also seen in our patient, are frequently recovered and support the diagnosis. Formation of HIV-1-specifi c antibodies marks seroconversion; antibodies are generally detectable by week 3-12, most frequently 4 -6 weeks after infection, although the window period may last up to 6 -12 months (12) .
Th e diagnosis of acute HIV infection (AHI) becomes rather diffi cult concerning the fact that routine HIV antibody tests (rapid HIV test or conventional enzyme immunoassay EIA, or Western blot) will typically remain negative at the time of peak viremia and the onset of symptoms. Th us, additional virus-specifi c diagnostic tests with a window period 1 -4 weeks after exposure, such as viral load tests also called PCR (polymerase chain reaction) tests for plasma HIV load (HIV plasma RNA), or HIV p24 antigen assay (ELISA) are needed to detect HIV infection prior to the appearance of antibodies. The results of a viral load test are described as the number of copies of HIV RNA in a millilitre of blood. HIV p24 is a major protein that is part of HIV and is detectable 2 -3 weeks after infection -before antibodies are produced, but not really afterwards -and p24 levels only stay high for the next 1 -2 months. Assays that measure plasma HIV-1 load are more preferable because sensitivity of p24 antigen assay is time dependent, and p24 antigenemia may wane during AHI (12) . Routine detection of HIV-1 plasma RNA by PCR is not currently approved by the US Food and Drug Administration for diagnosing HIV-1 infection unless history of recent high risk exposure (e.g. condom break with a known HIV-positive partner) and symptoms consistent with HIV seroconversion (fever, extreme tiredness, heavy "fl u-like" illness etc.) are present, as in our patient (12) . If it is positive, it must be confi rmed with another test, either Western blot or antibody test that diff erentiates HIV-1 and HIV-2. Since EIA detects antibodies to HIV-1 and HIV-2, a routine confi rmatory Western blot which is specifi c to HIV-1 is needed. When present alone, the HIV antibody test is considered to be indeterminate. Th is situation is frequently seen during seroconversion and should prompt correlation with the HIV-1 plasma RNA level, which was done in our patient. Th e diagnosis of primary HIV infection, also termed AHI, in our patient was based on the positive plasma HIV RNA test in conjunction with a indeterminate count to reduce the risk of disease progression and for prevention of HIV transmission (21) .
Th is report reviews a previously healthy male patient with primary syphilis and HIV-1, emphasing the importance of testing all persons with a new diagnosis of HIV for syphilis, and vice versa (22, 23) . Additionally, it highlights the fact that syphilis agent may enhance the transmission of HIV. Aggressive control of genital ulcer diseases may off er one very feasible approach to reducing transmission of HIV infection.
Conclusion
As far as the world literature available to us is concerned, this is the fi rst case of co-infection of primary syphilis and HIV.
Abbreviations
HIV -human immunodefi ciency virus AIDS -acquired immune defi ciency syndrome STI -sexually transmitted infections HAART -highly active antiretroviral therapy MSM -men who have sex with men VDRL -Venereal Disease Research Laboratory EIA -T. Pallidum enzyme immunoassay TP-PA -Treponema pallidum particle agglutination ELISA -enzyme-linked immunosorbent assay AHI -acute HIV infection PCR -polymerase chain reaction RNA -ribonucleic acid FTA-ABS -fl uuorescent treponemal antibody absorption HIV antibody test, followed by a confi rmatory Western blot at a subsequent point in time (13) . On the other hand, the diagnosis of primary syphilis is easier, since sensitivity of the nontreponemal VDRL and rapid plasma reagin (RPR) tests are estimated to be 78 -86% and treponemal tests such as fl uuorescent treponemal antibody absorption (FTA-ABS) and TP-PA tests show a sensitivity of 84% for detecting primary syphilis (14) .
All genital ulcer diseases, particularly syphilis, represent an important risk factor for the acquisition of HIV infection (15) (16) (17) . Moreover, HIV-infected patients with syphilis may be among the most important transmitters of HIV infection due to continuous risky behavior, as well as biologic eff ects of genital ulcerations. Furthermore, in uncircumcised males, as in our patient, trauma and subsequently sexually transmitted infections are more likely to happen during intercourse on the area of highly vascular frenulum. Th us, circumcision can be considered an eff ective intervention for reducing HIV transmission by reducing the synergy that normally exists between HIV and other sexually transmitted infections (18) .
Male-to-female HIV transmission during vaginal intercourse is signifi cantly more likely than female-to-male HIV transmission (19) . However, high prevalence of sexually transmitted diseases among female sex workers contributes to high HIV transmission probability, like in our case.
HIV-infected patients diagnosed with syphilis do not have specifi c regimens and should be treated for syphilis with the same regimens as non-HIV-infected patients. Our patient was treated in accordance with the recommended regimen for the treatment of primary and secondary syphilis in adults: a single dose 2.4 million units benzathine penicillin G, i.m. (4).
After antiretroviral therapy was introduced, most clinicians agreed that HIV-positive patients with low CD4 counts should be treated, but no consensus was gained as to whether to treat patients with high CD4 counts. Th e only consensus was on treating patients with advanced immunosuppression (CD4 counts less than 350/μl) (20) . Th e newest World Health Organization Guidelines (dated September 30, 2015) recommend off ering antiretroviral therapy (ART) to everyone living with HIV, at any CD4 cell
Sifi lis i HIV u primarnoj koinfekciji − prikaz slučaja

Sažetak
Uvod. Sifi lis predstavlja jednu od prevalentnijih infekcija među ljudima koji su infi cirani virusom humane imunodefi cijencije (engl. human immunodefi ciency virus − HIV) i/ili žive sa sindromom stečene imunodefi cijencije (engl. acquired immune defi ciency syndrome − AIDS). Prevalencija koinfekcije uzročnikom sifi lisa kreće se 1−21% u Severnoj Americi, a 2−43% u Evropi. Značajan porast učestalosti infekcije uzročnikom sifi lisa registrovan je tokom poslednjih 10 godina u celom svetu, naročito posle uvođenja 1996. godine visoko aktivne retroviralne terapije za lečenje AIDS (engl. highly active antiretroviral therapy − HAART) i sve učestalijim upražnjavanjem nezaštićenog analnog seksa među muškarcima koji imaju seksualne odnose sa muškarcima (MSM). Štaviše, porastao je i broj slučajeva sifi lisa nastao heteroseksualnim prenošenjem sa profesionalnih seksualnih radnika, promiskuitetnim ponašanjem i migracijama. Prikaz slučaja. Tridesetjednogodišnji muškarac azijskog porekla, primljen je na bolničko lečenje zbog pojave bolnih ulceracija na mekom nepcu praćenih crvenililom jezika i jednog jasno ograničenog bezbolnog ulkusa sa tvrdim ivicama na penisu koji je pratila regionalna limfadenopatija. Po anamnestičkim podacima, promene su trajale nedelju dana. Istovremeno, na prijemu, pacijent je na licu imao multiple eritematozne papule, bio je febrilan, dehidriran i kahektičnog izgleda. Tokom 24 h pred prijem u bolnicu, započeo je uzimanje antibiotika, ali se stanje nije poboljšavalo uključujući i febrilnost. Pacijent je negirao postojanje ozbiljnijih zdravstvenih problema u prošlosti, putovanja ili uzimanje lekova u poslednjem vremenskom periodu. Istakao je da je imao samo jedan nezaštićen seksualni odnos oralnim i vaginalnim putem sa ilegalnom seksualnom profesionalnom radnicom četiri nedelje pre pojave promena. Insistirao je na podatku da nije imao nijedan seksualni odnos tokom prethodne tri godine. Relevantna laboratorijska ispitivanja su dala sledeće
